Electromed, Inc. to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

NEW PRAGUE, Minn.–(BUSINESS WIRE)–Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 16, 2023 at the Westin NY Grand Central in New York City.

Electromed’s management team will engage in investor 1x1s on Thursday, November 16, 2023.

About Electromed, Inc.

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.

Contacts

Brad Nagel, Chief Financial Officer

(952) 758-9299

[email protected]

Mike Cavanaugh, Investor Relations

ICR Westwicke

(617) 877-9641

[email protected]

Subscribe on LinkedIn

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.